AP NEWS

The 2018 Benign Prostatic Hyperplasia Market and Competitive Landscape in Europe - ResearchAndMarkets.com

December 7, 2018

DUBLIN--(BUSINESS WIRE)--Dec 7, 2018--The “Europe Benign Prostatic Hyperplasia Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

This latest research provides comprehensive insights into Benign Prostatic Hyperplasia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Benign Prostatic Hyperplasia market size and drug sales. This research also provides insights into Benign Prostatic Hyperplasia epidemiology and late stage pipeline.

The research is classified into following sections - Benign Prostatic Hyperplasia overview with definitions, symptoms, etiology, diagnosis, treatment options; Benign Prostatic Hyperplasia pipeline insights covering late stage clinical trials pipeline; Benign Prostatic Hyperplasia prevalence trends by countries; Benign Prostatic Hyperplasia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Benefits of this Research

Evaluate commercial market opportunities for Benign Prostatic Hyperplasia drugs Synthesize insights for business development & licensing Track market size, competitor drug sales, market shares in Benign Prostatic Hyperplasia market Develop in-depth knowledge of competition and markets Analyze sales data to update your brand planning trackers Develop tactics and strategies to take advantage of opportunities in the market Track market trends and analyze key events in Benign Prostatic Hyperplasia market Develop forecast models, healthcare frameworks, or economic models Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered

1. Benign Prostatic Hyperplasia: Disease Overview

2. Benign Prostatic Hyperplasia Pipeline Insights

3. Benign Prostatic Hyperplasia Epidemiology Analysis

4. Germany Benign Prostatic Hyperplasia Market Insights

5. France Benign Prostatic Hyperplasia Market Insights

6. Italy Benign Prostatic Hyperplasia Market Insights

7. Spain Benign Prostatic Hyperplasia Market Insights

8. UK Benign Prostatic Hyperplasia Market Insights

9. Europe Benign Prostatic Hyperplasia Market Insights

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/jf4pbm/the_2018_benign?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181207005248/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Prostate Cancer Drugs

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/07/2018 09:22 AM/DISC: 12/07/2018 09:22 AM

http://www.businesswire.com/news/home/20181207005248/en

AP RADIO
Update hourly